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ABSTRACT 
Microspheres are novel drug delivery approach to control release of pharmacologically active ingredient as per patient need. 
Natural polymers like fenugreek mucilage are cheap, biodegradable and have been proved safe for pharmaceutical formulation. 
Higher loading efficiency was observed for all the formulations and also the drug release was observed for the period of 12 
hours. Thus, the simvastatin microsphere using fenugreek mucilage showed promising results in retarding the drug release. It 
can be concluded from whole study that due to the formation of polymeric network system or other active moiety can be easily 
entrapped with the matrix and hydration and swelling of natural polymer controlled their release pattern 
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INTRODUCTION 
Microspheres are defined as “Monolithic sphere or 
therapeutic agent distributed throughout the matrix either 
as a molecular dispersion of particles” (or) can be defined as 
the structure made up of the continuous phase of one or 
more miscible polymers in which drug particles are 
dispersed at the molecular or macroscopic level. 
Microspheres are small spherical particles, with diameters in 
the micrometer range (typically 1 µm to 1000 µm). 
Microspheres are sometimes referred to as microparticles 
which are made of various polymers. Biodegradable 
synthetic polymers and modified natural products such as 
starches, gums, proteins, fats, and waxes are used. The 
natural polymers include albumin and gelatin, the synthetic 
polymer includees polylactic acid and polyglycolic acid. The 
solvents used to dissolve the polymeric materials are chosen 
according to the polymer and drug solubility, stabilities, 
process safety and economic considerations (Chein, 1992). 
Microspheres for oral use have been employed to sustain the 
drug release and to reduce or eliminate gastrointestinal tract 
irritation. In addition, multi particulate delivery systems 
spread out more uniformly in the gastrointestinal tract. This 
results in more reproducible drug absorption and reduces 
local irritation when compared to single-unit dosage forms 
such as no disintegrating, polymeric matrix tablets. 
Unwanted intestinal retention of the polymeric material, 
which may occur with matrix tablets on chronic dosing, can 
also be avoided (Mathew et al., 2008). 
Therapeutic action (Sipai Altaf et al., 2012; Hardenia, et al., 
2011; Anandea et al., 2008).Adhesion can be defined as 
sticking of a drug to the membrane by using the sticking 
property of the water-soluble polymers. Adhesion of drug 
delivery device to the mucosal membrane such as buccal, 
ocular, rectal, nasal etc. can be termed as bio-adhesion. These 
kinds of microspheres exhibit a prolonged residence time at 
the site of application and cause intimate contact with the 
absorption site. 
In floating types, the bulk density is less than the gastric fluid 
and so remains buoyant in the stomach without affecting the 
gastric emptying rate. The drug is released slowly at the 
desired rate if the system is floating on gastric content and 
increases gastric residence and increases fluctuation in 
plasma concentration. Moreover, it also reduces the chances 
of striking and dose dumping. One another way it produces a 
prolonged therapeutic effect and therefore reduces dosing 
frequencies (Dutta et al., 2001; Kawashima et al., 1991). 
The ability to incorporate reasonably high concentrations of 
the drug. Stability of the preparation after synthesis with a 
clinically acceptable shelf life. Controlled particle size and 
dispersibility in aqueous vehicles for injection. Release of 
active reagent with a good control over a wide time scale. 
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Biocompatibility with a controllable biodegradability. 
Susceptibility to chemical modification.  ( Mohan et al., 2014; 
SreeGiri et al., 2014) 
MATERIAL & METHOD 
Formulation Development 
Extraction and Isolation of Fenugreek mucilage 
The clean, dry fenugreek seeds were grounded under 
 mild conditions using a laboratory mixer. The grounded 
seeds were then sieved to remove the germ which possesses 
the lowest hardness. The remaining part was soaked 
overnight in water, to allow the gum to swell. The swelled 
gum was separated from the other components of the seeds 
via filtration through a muslin cloth. 
The separated gum was either used as it is, i.e. in the viscous 
form or precipitated using commercial ethyl alcohol, dried 
and finally grinded to fine powder (Ragheb et al., 2015).
 
 
 
Isolated Gum            Dry Gum 
Figure 1: Extraction and Isolation of Fenugreek mucilage 
Evaluation of mucilage 
Determination of percentage yield 
Percentage yield of mucilage was determined using this 
formula. 
Determination of swelling index 
The swelling index is the volume in ml occupied by 1g of 
drug; including any adhering mucilage after it has been 
swollen in an aqueous liquid for 4h .The swelling index of 
Fenugreek mucilage powder, was determined according to 
the (BP, 2001). One gram of mucilage powder was taken in a 
25 ml ground glass stoppered cylinder graduated over a 
height of 120 to 130 mm in 0.5 divisions. To this 25 ml of 
water was added and this was shaken vigorously every 10 m 
for 1h and then allowed to stand for 24 h. The volume 
occupied by mucilage was measured. The Swelling index was 
calculated from the mean of three determinations. 
Swelling Index % (SI) = (W2 – W1/W1) x 100  
W1= Initial Volume in ml   
W2= Final Volume in ml   
Loss on drying of isolated gum 
The moisture in a solid can be expressed on a wet weight or 
dry wet basis. On a wet weight basis, the water content of a 
material is calculated as a percentage of the weight of the 
weight solid. The term loss on drying is an expression of 
moisture content on a wet weight basis. 
Procedure: 
Loss on drying is directly measured by IR moisture balance 
(Labgo Infrared Moisture Balance). Firstly calibrated the 
instrument by knob then taken 5.000 gm sample (powder) 
and set the temp at 100°C to 105°C for 15 minutes and 
constant reading set the knob and check % moisture. 
Preparation of mucoadhesive microsphere 
Chitosan microspheres were prepared by ionotropic gelation 
method. 
Preparation I: Chitosan stock solution (1% w/v) was 
prepared by dissolving chitosan in acetic acid (1% v/v) at 
room temperature. 
Preparation II: The drug and sodium alginate was dissolved 
in 10 ml of water. 
Preparation III: 1% Sodium tripolyphosphate solution was 
prepared. 
Preparation IV: Solution of preparation I was slowly added 
in preparation III with continuous starring on magnetic 
stirrer. 
Preparation II was added in preparation IV through a 
disposable syringe needle into a gently agitating. The 
dropping rate and falling distance were kept constant. The 
solution was magnetically stirred for half an hour followed 
by filtration and rinsing with distilled water. Gel like beads 
were obtained which was air dried for twenty four hours 
followed by oven drying for six hours at 40˚C.
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Table 1: Different formulations of simvastatin 
 
 
Evaluation of microspheres 
Percentage Yield 
The prepared microspheres with a size range of 200-300nm 
were collected and weighed from different formulations. The 
measured weight was divided by the total amount of all non-
volatile components which were used for the preparation of 
the microspheres (Rajinikanth et al., 2008). 
 
 
Figure 2: Formulated microsphere 
 Drug Entrapment 
The various formulations of the mucoadhasive microspheres 
were subjected for drug content. 10 mg of mucoadhasive 
microspheres from all batches were accurately weighed and 
crushed. The powder of microspheres were dissolved in 10 
ml 1.2 pH Buffer and centrifuge at 1000 rpm. This 
supernatant solution is than filtered through Whatman filter 
paper No. 44. After filtration, from this solution 0.1 ml was 
taken out and diluted up to 10 ml with 1.2 pH Buffer. The 
percentage drug entrapment was calculated using 
calibration curve method. 
 Measurement of mean particle size 
The mean size of the microspheres was determined by Photo 
Correlation Spectroscopy (PCS) on a submicron particle size 
analyzer (Malvern Instruments) at a scattering angle of 90°. 
A sample (0.5mg) of the microspheres suspended in 5 ml of 
distilled water was used for the measurement (Kamel et al., 
2001).   
Determination of zeta potential 
The zeta potential of the drug-loaded microspheres was 
measured on a zeta sizer (Malvern Zetasizer) by determining 
the electrophoretic mobility in a micro electrophoresis flow 
cell. All the samples were measured in water at 25°C in 
triplicate (Kamel et al., 2001).   
Shape and Surface Characterization of Microspheres by 
Scanning Electron Microscopy (SEM) 
From the formulated batches of microspheres, formulations 
(F4) which showed an appropriate balance between the 
percentage releases were examined for surface morphology 
and shape using scanning electron microscope Jeol Japan 
6000. Sample was fixed on carbon tape and fine gold 
sputtering was applied in a high vacuum evaporator. The 
acceleration voltage was set at 10KV during scanning. 
Microphotographs were taken on different magnification 
and higher magnification (200X) was used for surface 
morphology (Kamelet al.,2001). 
 In-vitro Release Studies 
7.4.6.1 In vitro drug release in simulated gastric fluid 
The prepared microsphere was evaluated for in vitro drug 
release. The drug release studies were carried out using USP 
XXII paddle type Dissolution test apparatus. The dissolution 
study was carried out in 900 ml dissolution medium which 
was stirred at 100 rpm maintained at 37±0.2°C.   
A weighed quantity of formulation (100 mg) was spread 
over the surface of dissolution media (900 ml) at 37±0.2°C. 
Samples were withdrawn at different time interval and 
compensated with same amount of fresh dissolution 
medium. Volume of sample withdrawn was made up to 10ml 
by continuous media. The samples withdrawn were assayed 
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spectrophotometrically at 232.0 nm for simvastatin and 
using UV visible spectrophotometer. The release of 
simvastatin was calculated with the help of Standard curve 
of simvastatin. 
 Drug release kinetic data analysis 
Several kinetic models have been proposed to describe the 
release characteristics of a drug from matrix. The following 
three equations are commonly used, because of their 
simplicity and applicability. Equation 1, the zero-order 
model equation (Plotted as cumulative percentage of drug 
released vs time); Equation 2, Higuchi’s squareroot equation 
(Plotted as cumulative percentage of drug released vs square 
root of time); and Equation 3, the Korsemeyer-Peppas 
equation (Plotted as Log cumulative percentage of drug 
released vs Log time). 
To study the release kinetics of simvastatin from the 
Mucoadhasive microspheres the release data was fitted to 
these four equations 
Zero order equation: When a graph of the cumulative 
percentage of the drug released from the matrix against time 
is plotted, zero order release is linear in such a plot, 
indicating that the release rate is independent of 
concentration. 
Qt = k0.t  
Where Qt is the percentage of drug released at time t and k0 is 
the release rate constant; 
First order equation 
In (100-Qt) = In 100- kI.t  
 Where kI is the release rate constant; 
Higuchi’s equation 
Qt = kH.t1/2    
 Where KH is the Higuchi release rate constant 
Korsemeyer-Peppas 
The curves plotted may have different slopes, and hence it 
becomes difficult to exactly pin-point which curve follows 
perfect zero order release kinetics. Therefore, to confirm the 
kinetics of drug release, data were also analyzed using 
Korsemeyer’s equation. 
                                     Qt/Q∞ = kKP.tn 
Where Qt/ Q∞ is the fraction of drug released at time t, kKPa 
constant compromising the structural and geometric 
characteristics of the device and n is the release exponent. 
The slope of the linear curve gives the ‘n’ value. Peppas 
stated that the above equation could adequately describe the 
release of solutes from slabs, spheres, cylinders and discs, 
regardless of the release mechanism. The value of ‘n’ gives 
an indication of the release mechanism. When n = 1, the 
release rate is independent of time (typical zero order 
release / case II transport); n = 0.5 for Fickian release 
(diffusion/ case I transport); and when 0.5 < n < 1, 
anomalous (non-Fickian or coupled diffusion/ relaxation) 
are implicated. Lastly, when n > 1.0 super case II transport is 
apparent.  ‘n’ is the slope value of log Mt/M∞   versus log time 
curve. 
 Stability studies for optimized formulation 
The purpose of stability testing is to provide evidence on 
how the quality of a drug substance or drug product varies 
with time under the influence of a variety of environmental 
factors such as temperature, humidity and light and to 
establish a retest period for the drug substance or a shelf life 
for drug product and recommended storage conditions. In 
general, a drug substance should be evaluated under storage 
condition (with appropriate tolerances) that test its thermal 
stability and if applicable, its sensitivity to moisture. Three 
types of storage conditions are used i.e. long term, 
Accelerated and where appropriate, Intermediate. 
Accelerated Testing, are the studies designed to increase 
the rate of chemical degradation or physical change of a drug 
substance or drug product by using exaggerated storage 
conditions as part of the formal stability studies. 
The optimized formulation F4 was taken and accelerated 
stability study was performed by taking suitable quantity of 
microspheres. The microspheres were placed in air-tight 
glass container at 40±2°C/75±5% RH. At suitable sampling 
interval the samples were withdrawn and evaluated for 
various parameters. 
 Sampling Intervals 
Storage conditions Sampling intervals 
Real time storage 30°C/75% RH 0, 3, 6, 9, 12, 18, 24, 36, 48, 60, 
months 
Accelerated 40°C/75% RH 0, 1, 3, 6 months 
 
RESULTS AND DISCUSSION 
The percentage yield of mucilage was found to be 61%. 
Physio-chemical characterization of mucilage 
The separated mucilage was evaluated for swelling index, 
loss on drying, density, compressibility index and angle of 
repose. 
Table 2: Physio-chemical characterization of mucilage 
S. No Characterization Results 
1. Appearance Mucilaginous 
2. Color Brown 
3. State Solid 
 
The swelling index of isolated mucilage was found to be 
62.32 ±0.637%. 
The loss on drying of isolated mucilage was found to be 
74.066±0.0498%. 
Evaluation of simvastatin microspheres 
 Percentage Yield 
Percentage yield of different formulation was determined by 
weighing the Microspheres after drying.  The percentage 
yield of different formulation was in range of 61.25±0.23–
78.85±0.65% 
Table 3: Percentage Yield of Different Formulation 
Formulation Code Percentage Yield* 
F1 65.58±0.45 
F2 70.23±0.32 
F3 73.36±0.45 
F4 78.85±0.65 
F5 61.25±0.23 
F6 69.98±0.74 
*Average of three determination (n=3) 
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Drug Entrapment 
The drug entrapment of different formulations was in range 
of 78.05- 83.25% w/w.  
Table 4: Drug Entrapment for Different Formulation 
Formulation 
Drug entrapment (% w/w) of 
prepared microsphere* 
F1 75.65±0.23 
F2 72.23±0.45 
F3 69.98±0.65 
F4 82.21±0.21 
F5 70.12±0.36 
F6 65.45±0.74 
*Average of three determination (n=3) 
 
This is due to the permeation characteristics of HPMC that 
could facilitate the diffusion of part of entrapped drug to 
surrounding medium during preparation of simvastatin 
microspheres. 
The maximum Percentage Yield, Drug Entrapment was 
found to be formulation F4. The optimized formulation of 
batches subjected to further studies. 
Particle size analysis 
The mean size of the microspheres was determined by photo 
correlation spectroscopy (PCS) on a submicron particle size 
analyzer (Malvern zetasizer) at a scattering angle of 90°. A 
sample (0.5mg) of the microspheres suspended in 5 ml of 
distilled water was used for the measurement. The results of 
measurement of mean particle size of optimized formulation 
F4 microsphere were found 205.5 nm respectively.
 
 
 
Figure 3: Particle size data of mucoadhesive microsphere 
 
Zeta Potential 
The zeta potential of the drug-loaded microspheres was 
measured on a zeta sizer (Malvern Instruments) by 
determining the electrophoretic mobility in a micro 
electrophoresis flow cell. All the samples were measured in 
water at 25°C in triplicate.  Results of zeta potential of 
optimized formulation F4 microsphere were found -35.6 mV 
respectively. 
 
Figure 4: Zeta potential data of mucoadhesive 
microsphere 
 Scanning Electronic Microscopy 
Shape and surface characteristic of Simvastatin 
microspheres exam in by Scanning Electronic Microscopy 
analysis.  Surface morphology of formulation examines at 
two different magnifications 55X which illustrate the smooth 
surface of mucoadhesive Microspheres. 
 
Figure 5: Scanning Electronic Microscopy image of 
optimized formulation F-4 
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Table 5: Cumulative % drug release of simvastatin from optimized formulation of microsphere 
 
S. No. 
 
 
Time (hrs) 
 
    % Cumulative Drug Release* 
1 0.5 14.56±0.36 
2 1 22.36±0.25 
3 2 36.65±0.24 
4 3 48.89±0.36 
5 4 52.23±0.56 
6 6 66.69±0.47 
7 8 73.32±0.65 
8 10 84.89±0.78 
9 12 94.23±0.32 
*Average of three determination (n=3)
Table 6: In Vitro Drug Release Data for Coated formulation 
S. 
No. 
Time 
(H) 
Square 
Root of 
Time 
Log 
Time 
Cumulative* 
Percentage Drug 
Release±SD 
Log 
Cumulative 
Percentage 
Drug 
Release 
Cumulative 
Percent 
Drug 
Remaining 
Log 
cumulative 
Percent 
Drug 
Remaining 
1 0.5 0.707 -0.301 14.56 1.163 85.44 1.932 
2 1 1.000 0.000 22.36 1.349 77.64 1.890 
3 2 1.414 0.301 36.65 1.564 63.35 1.802 
4 3 1.732 0.477 48.89 1.689 51.11 1.709 
5 4 2.000 0.602 52.23 1.718 47.77 1.679 
6 6 2.449 0.778 66.69 1.824 33.31 1.523 
7 8 2.828 0.903 73.32 1.865 26.68 1.426 
8 10 3.162 1.000 84.89 1.929 15.11 1.179 
9 12 3.464 1.079 94.23 1.974 5.77 0.761 
* Average of three determinations (n=3) 
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Figure 7: Cumulative Percent Drug Released Vs Time (Zero Order Plots) 
 
Figure 7: Log Cumulative Percent Drug Remaining Vs Time (First Order Plots) 
 
Figure 8: Log Cumulative Percent Drug Released Vs Log Time (Peppas Plots) 
Regression Analysis Data of mucoadhasive microspheres Formulation 
Formulation     Zero order  First order  Pappas plot 
F3          y = 6.518x+21.19          y = -0.089x + 2.008 y = 0.579x –1.363 
          R² = 0.951  R² = 0.948  R² = 0.991 
 
 Stability studies 
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Stability studies were carried out with optimized formulation 
which was stored for a period of 45 days at 4±1°C, RT and 
40±1°C. The particle size of formulation was determined by 
optical microscopy using a calibrated ocular micrometer. The 
particle size of the microsphere was found to increase at RT, 
which may be attributed to the aggregation of microsphere 
at higher temperature. At 45±2°C the microsphere aggregate 
i.e. these microsphere were unstable at higher temperature 
like 45±2°C. Percent efficiency of mucoadhesive 
Microspheres also decrease at higher temperature Like 
45±2°C. 
CONCLUSION:  
Microspheres are novel drug delivery approach to control 
release of pharmacologically active ingredient as per patient 
need. Natural polymers like fenugreek mucilage are cheap, 
biodegradable and have been proved safe for pharmaceutical 
formulation. Higher loading efficiency was observed for all 
the formulations and also the drug release was observed for 
the period of 12 hours. Thus, the simvastatin microsphere 
using fenugreek mucilage showed promising results in 
retarding the drug release. It can be concluded from whole 
study that due to the formation of polymeric network system 
or other active moiety can be easily entrapped with the 
matrix and hydration and swelling of natural polymer 
controlled their release pattern 
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